Brief: Pixium Vision: First Patient Implantation In PRIMAvera In Netherlands
26/07/2022 06:02
July 26 (Reuters) - PIXIUM VISION SA ALPIX.PA :
* PIXIUM VISION ANNOUNCES SUCCESSFUL IMPLANTATION OF FIRST
PATIENT
IN THE NETHERLANDS IN PRIMA SYSTEM EUROPEAN PIVOTAL TRIAL
PRIMAVERA
* PRIMAVERA CLINICAL SITE OPENS AT ROTTERDAM EYE HOSPITAL IN
NETHERLANDS
* - FOLLOWS SUCCESSFUL IMPLANTATIONS AT CLINICAL SITES IN
FRANCE,
GERMANY AND UK
* NEW CLINICAL SITES TO OPEN IN SPAIN AND ITALY
* PRIMAVERA READ-OUT EXPECTED AROUND END OF 2023
* ANTICIPATES RECRUITMENT WILL BE COMPLETED BY END OF 2022
Source text for Eikon: ID:nGNX7rsNTM
Further company coverage: ALPIX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))
Recent news on Pixium Vision SA
See all newsBrief: Pixium Vision SA Says Paris Commercial Court Postponed Decision On Takeover Offer Filed On Nov 20, 2023
Brief: Pixium Vision: opening of judicial liquidation proceedings has been postponed to later date
Brief: Pixium Vision Announces Decision About Adoption Of Sale Plan, Opening Of Judicial Liquidation Proceedings Planned For Jan 16, 2024
Brief: Pixium Vision SA Announces Conversion Of Safeguard Proceedings Into Receivership
Brief: Pixium Vision Announces Tender Process For Purpose Of Finding Buyers To Acquire Company's Business Will Be Published Tomorrow